TheGMP Cytokines Market size is projected to reach US$ 350.2 million by 2031 from US$ 128.7 million in 2023. The market is expected to register a CAGR of 9.7% in 2023–2031. Technologically advanced GMP cytokines production is likely to remain a key GMP cytokines market trend.
GMP cytokines utility in cancer therapy, use of cytokines as a potential biomarker for neonatal sepsis, and cytokines for stem cell therapy are the most influential factors responsible for market growth. Additionally, research & development (R&D) activities further drives the market growth during 2021-2031. Further, High Grade-GMP- cytokines production and optimization by the manufacturers will provide lucrative market opportunities in the coming years.
Cytokines are critically raw materials for T cell and NK cell therapy manufacturing. For example, PeproGMP Cytokines provide safety, purity, and simplified use in ex vivo manufacturing processes. Additionally, MACS GMP Cytokines offer a large variety of highly active and pure cytokines that perfectly meet the requirements for high-quality raw materials intended for cell manufacturing for cell-based therapies. Therefore, innovative product launches of GMP cytokines may act as an influential factor responsible for market growth.
Cytokines are used in clinical research, such as clinical cancer therapy. For example, cytokines stimulate the function, survival, and proliferation of Natural Killer (NK) and T Cells that mediate immune response against tumors. For example, the MACS GMP Cytokine Portfolio offers ex-vivo cell culture in clinical research. Therefore, for rising clinical research for cytokines, manufacturers are developing high standards cytokines. For example, cytokines used for stem cell research should be low-endotoxin, free from microbes, animal products, and potential toxins. Also, cytokines have to be filtered for purity and tested for adequate biological activity. An example of such GMP cytokines is cytokines “T cell and NK cell” produced through ScaleReady manufacturing. GMP cytokines are critical raw materials for manufacturing T cell and NK cell therapy. The aforementioned factors positively influence the market growth of GMP cytokines during 2021-2031.
Currently, cytokines manufacturers are developing effective strategies for high throughput and effective optimization techniques. BioTechne is an example of such a manufacturer focussing on producing autologous T cell therapies targeting solid tumors cancers. The company seeks to develop innovative methods of cytokine supplementation, reduce cytokine waste, improve dose accuracy across lots, and decrease process risk. A feasibility study was done to monitor clinical effectiveness and optimization techniques for cytokines. Additionally, the company is pursuing to deliver process-fit activity for the residual cytokine products, eliminating GMP cytokine waste. Therefore, producing high Grade-GMP with effective process optimization will ultimately lead to a good quality manufacturing practices to deliver effective output will drive the market in the coming years.
Key segments that contributed to the derivation of the GMP cytokines market analysis are contaminants, technology, and food type.
The geographic scope of the GMP cytokines market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
The GMP cytokines market in North America is significantly In North America, the GMP cytokines market is currently in the growth phase and experiencing exponential growth. In North America, the US accounts largest share for the GMP cytokines market. Presence of top biotechnology companies and innovative product launches are the most influential growth factors driving the North America region growth positively. Further, Asia Pacific will account highest CAGR for GMP cytokines market during 2021-2031.
The regional trends and factors influencing the GMP Cytokines Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses GMP Cytokines Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 128.7 Million |
| Market Size by 2031 | US$ 350.2 Million |
| Global CAGR (2023 - 2031) | 9.7% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The GMP Cytokines Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the GMP Cytokines Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The GMP cytokines market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:
The “GMP Cytokines Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas: